Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin effect on Dabigatran PK/PD
NCT03728101Phase 1Completed
- Sponsor
- Korea University Guro Hospital
- Start
- Nov 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of dabigatran in thromboembolism, sponsored by Korea University Guro Hospital. Primary endpoints: Maximum Plasma Concentration at 24 hours and Area Under the Curve at 24 hours. Started Nov 2018; status: completed.
02
Drugs
dabigatran
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT03728101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03728101.